Authors:
Santini, D
Vincenzi, B
Fossati, C
D'Angelillo, RM
Patti, G
Bianco, V
Avvisati, G
Tonini, G
Citation: D. Santini et al., Prevention of delayed emesis induced by moderately emetogenic chemotherapyin patients with acute emesis - A pilot study with ACTH-Depot plus tropisetron, MED ONCOL, 18(2), 2001, pp. 131-135
Authors:
Dragoni, F
Tormene, D
Simioni, P
Arcieri, P
Avvisati, G
Girolami, A
Citation: F. Dragoni et al., ProC global: A new automated screening assay for the evaluation of total function of the protein C system, CL APPL T-H, 7(4), 2001, pp. 351-355
Authors:
Torromeo, C
Latagliata, R
Avvisati, G
Petti, MC
Mandelli, F
Citation: C. Torromeo et al., Intraventricular thrombosis during all-trans retinoic acid treatment in acute promyelocytic leukemia, LEUKEMIA, 15(8), 2001, pp. 1311-1313
Authors:
Specchia, G
Lo Coco, F
Vignetti, M
Avvisati, G
Fazi, P
Albano, F
Di Raimondo, F
Martino, B
Ferrara, F
Selleri, C
Liso, V
Mandelli, F
Citation: G. Specchia et al., Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: A report by the Gruppo Italiano Malattie Ematologiche dell'Adulto, J CL ONCOL, 19(20), 2001, pp. 4023-4028
Authors:
Gastaldi, R
Martino, P
Gentile, G
Cafolla, A
Cordone, I
Giannini, G
Torromeo, C
Palmisano, L
Picardi, V
Andreotti, M
Avvisati, G
Mandelli, F
Citation: R. Gastaldi et al., High dose idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin's lymphoma patients: a pilot study, HAEMATOLOG, 86(10), 2001, pp. 1051-1059
Authors:
Dragoni, F
Minotti, C
Palumbo, G
Faillace, F
Redi, R
Bongarzoni, V
Avvisati, G
Citation: F. Dragoni et al., As compared to kaolin clotting time, silica clotting time is a specific and sensitive automated method for detecting lupus anticoagulant, THROMB RES, 101(2), 2001, pp. 45-51
Citation: G. Avvisati et al., Acute promyelocytic leukemia: Clinical and morphologic features and prognostic factors, SEM HEMATOL, 38(1), 2001, pp. 4-12
Authors:
Casassus, P
Gibson, J
Joshua, DE
Matthews, J
Diaz, JC
Gertz, MA
Kyle, R
Leong, T
Oken, MM
Fritz, E
Ludwig, H
Corrado, C
Lastiri, F
Peest, D
Grosbois, B
Vela-Ojeda, J
Avvisati, G
Mandelli, F
Petrucci, MT
Capnist, G
Child, JA
Drayson, MT
Dunn, J
MacLennan, I
Mellstedt, H
Osterborg, A
Rodjer, S
Turesson, I
Westin, J
Bergsagel, D
Browman, GP
Shustik, C
Zee, B
Hjorth, M
Holmberg, E
Rodjer, S
Turesson, I
Westin, J
Alison, R
Clarke, M
Elphinstone, P
Evans, V
Gray, R
Hicks, C
James, S
MacKinnon, L
Peto, R
Richards, S
Wheatley, K
Blade, J
Fontanillas, M
San Miguel, J
Aitchison, R
Newland, AC
Cunningham, D
Malpas, J
Powles, RL
Montuoro, A
Jacobson, J
Salmon, S
Citation: P. Casassus et al., Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients, BR J HAEM, 113(4), 2001, pp. 1020-1034
Authors:
Pagano, L
Pulsoni, A
Tosti, ME
Avvisati, G
Mele, L
Mele, A
Martino, B
Visani, G
Cerri, R
Di Bona, E
Invernizzi, R
Nosari, A
Clavio, M
Allione, B
Coser, P
Candoni, A
Levis, A
Camera, A
Melillo, L
Leone, G
Mandelli, F
Citation: L. Pagano et al., Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia, BR J HAEM, 112(1), 2001, pp. 109-117
Authors:
Lo Coco, F
Diverio, D
De Santis, S
Avvisati, G
Saglio, G
Biondi, A
Mandelli, F
Citation: F. Lo Coco et al., Molecular diagnosis and monitoring of acute promyelocytic leukemia: Updated results of the Italian GIMEMA Group, HEMAT BLOOD, 40, 2001, pp. 562-564
Authors:
Petrucci, MT
La Verde, G
Ribersani, M
Avvisati, G
Mandelli, F
Citation: Mt. Petrucci et al., Intravenous melphalan and dexamethasone followed by lymphoblastoid alpha interferon in higher risk multiple myeloma patients, LEUK LYMPH, 39(1-2), 2000, pp. 131-138
Authors:
Martelli, MP
Latagliata, R
Spadea, A
Avvisati, G
Mancini, M
Romano, A
Luzi, G
Petti, MC
Citation: Mp. Martelli et al., Molecular and cytogenetic remission in a case of subtype M4E acute myelogenous leukemia with minimal monochemotherapy: high sensitivity or spontaneous remission?, EUR J HAEMA, 65(3), 2000, pp. 203-206
Authors:
Tribalto, M
Amadori, S
Cudillo, L
Caravita, T
Del Poeta, G
Meloni, G
Avvisati, G
Petrucci, MT
Pulsoni, A
Leone, G
Sica, S
Martelli, M
Tabilio, A
Fioritoni, G
Majolino, I
Mandelli, F
Citation: M. Tribalto et al., Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian multicenter study, HAEMATOLOG, 85(1), 2000, pp. 52-58
Authors:
Di Bona, E
Avvisati, G
Castaman, G
Vegna, ML
De Sanctis, V
Rodeghiero, F
Mandelli, F
Citation: E. Di Bona et al., Early haemorrhagic morbidity and mortality during remission induction withor without all-trans retinoic acid in acute promyelocytic leukaemia, BR J HAEM, 108(4), 2000, pp. 689-695
Authors:
Mengarelli, A
Minotti, C
Palumbo, G
Arcieri, P
Gentile, G
Iori, AP
Arcese, W
Mandelli, F
Avvisati, G
Citation: A. Mengarelli et al., High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogeneic stem celltransplantation, BR J HAEM, 108(1), 2000, pp. 126-131
Authors:
Sanz, MA
Lo Coco, F
Martin, G
Avvisati, G
Rayon, C
Barbui, T
Diaz-Mediavilla, J
Fioritoni, G
Gonzalez, JD
Liso, V
Esteve, J
Ferrara, F
Bolufer, P
Bernasconi, C
Gonzalez, M
Rodeghiero, F
Colomer, D
Petti, MC
Ribera, JM
Mandelli, F
Citation: Ma. Sanz et al., Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups, BLOOD, 96(4), 2000, pp. 1247-1253
Authors:
Torromeo, C
Latagliata, R
Avvisati, G
Petti, MC
Mandelli, F
Citation: C. Torromeo et al., Coronaric thrombotic events in acute promyelocytic leukemia during all-trans retinoic acid treatment: a role for adhesion molecules overexpression?, LEUKEMIA, 13(2), 1999, pp. 312-313
Authors:
Lo Coco, F
Diverio, D
Avvisati, G
Petti, MC
Meloni, G
Pogliani, EM
Biondi, A
Rossi, G
Carlo-Stella, C
Selleri, C
Martino, B
Specchia, G
Mandelli, F
Citation: F. Lo Coco et al., Therapy of molecular relapse in acute promyelocytic leukemia, BLOOD, 94(7), 1999, pp. 2225-2229
Authors:
Pasquali, S
Maqueo, JD
Vela, J
Kyle, RA
Leong, T
Fritz, E
Suciu, S
Palva, IP
Oivanen, T
Corrado, C
Lastiri, FJ
Peest, D
Kildahl-Andersen, O
Maniatis, A
Alison, R
Clarke, M
Evans, V
Gray, R
Greaves, E
Hall, E
Hicks, C
James, S
Peto, R
Richards, S
Sinclair, D
Tooth, A
Wheatley, K
Avvisati, G
Boccadoro, M
Bugliosi, R
Mandelli, F
Petrucci, MT
Pileri, A
Tribalto, M
Alexanian, R
Delasalle, KB
Child, J
Dunn, J
MacLennan, I
Milligan, D
Mellstedt, H
Osterborg, A
Hjorth, M
Holmberg, E
Rodjer, S
Westin, J
Kamiya, O
Shimizu, K
Bergsagel, DE
Shustik, C
Hippe, E
Kjaersgaard, E
Turesson, I
Westin, J
Riccardi, A
Ucci, G
Blade, J
Fontanillas, M
De Rosa, L
Montuoro, A
Bartolucci, AA
Omura, GA
Stagg, M
Salmon, S
Tangen, C
Jacobs, P
Wood, L
Levy, LM
Citation: S. Pasquali et al., Combination chemotherapy versus melphalan plus prednisone as treatment formultiple myeloma: An overview of 6,633 patients from 27 randomized trials, J CL ONCOL, 16(12), 1998, pp. 3832-3842